Arnold Milstein MD Arnold Milstein MD Paul Schimmel PhD Charles G. Hadley,General Partner    

Jonathan Bush

Arnold Milstein

Paul Schimmel

Alan Ezekowitz

Charles G. Hadley

Alan Ezekowitz joined Cardinal Partners as an Entrepreneur in-Residence in 2011. He is Co-Founder, President and CEO of Abide Therapeutics, a company co-founded by Professors Dale Boger and Ben Cravatt from the Scripps Research Institute. He was previously Senior Vice President and Franchise Head, Bone, Respiratory, Immunology, and Endocrine at Merck Research Laboratories; he joined Merck in 2006 and retired in March 2011. At Merck, he was responsible for the overall scientific direction of the drug discovery and development process for Merck's key therapeutic areas of immunology, respiratory disease, and endocrine disorders. Prior to Merck, Alan worked at Mass General, where he had served as chief of Pediatric Services and chaired the Executive Committee on Research. He also served as chief of Pediatric Services for Partners HealthCare System in Boston and the Charles Wilder Professor of Pediatrics at Harvard Medical School.

He severed on the Board of Directors of the Partners Healthcare System and MassGeneral Physicians Organization. He also served on the Boards of Anika Therapeutics and Natimmune, a biotech company that he founded. In 2008 he was honored with the establishment R. Alan Ezekowitz Professorship in Pediatrics at the Harvard Medical School. Prior to joining the staff of Mass General in 1995, he served on the staff of Children's Hospital in Boston for 11 years.

Dr. Ezekowitz received his medical training at the University of Cape Town in South Africa and was awarded a Doctor of Philosophy degree from Oxford University where he also completed a postdoctoral fellowship. At Children's Hospital in Boston, he completed a second postdoctoral fellowship in the Division of Hematology and Oncology.